SUBSCRIBE
SUBSCRIBE

Panbela Therapeutics Inc.

IN THE PRESS
Business
Corrected: Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
March 26, 2021
 · 
12 min read
Business
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
March 25, 2021
 · 
11 min read
BioMidwest
Panbela Schedules Conference Call on March 25, 2021 to Report 2020 Fourth Quarter Financial Results
March 17, 2021
 · 
5 min read
Business
Panbela Appoints Industry Veteran, Garry A. Weems, PharmD, as Vice President of Clinical Development & Medical Affairs
March 15, 2021
 · 
6 min read
BioMidwest
Panbela to Participate in Upcoming Virtual Investor Conferences
March 8, 2021
 · 
4 min read
BioMidwest
Panbela Announces Research Agreement with Johns Hopkins University School of Medicine
February 10, 2021
 · 
4 min read
BioMidwest
Panbela Provides Update on Current Clinical Trial: Decision to Hold Administration of SBP-101
February 10, 2021
 · 
6 min read
Drug Development
Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer· Phase 1b Data Expected 1H 2021
December 8, 2020
 · 
5 min read
BioMidwest
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
December 1, 2020
 · 
4 min read
Business
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
November 12, 2020
 · 
11 min read
Load More
JOBS